CME Group reported a substantial rise in its Q3
profit, attributed to traders seeking a safe haven from market volatility by
using CME Group’s products. The company reported a revenue of $1.3 billion and
operating income of $820 million.
CME Group’s net income surged to $807.8 million, or
$2.25 per share, for the quarter ending on September 30. This marked a significant
improvement of 13.7% from the $710 million, or $1.98 per share, reported during
the same period the previous year.
CME Group‘s Chairman and Chief Executive Officer, Terry Duffy, stated: “CME Group delivered its ninth consecutive quarter of
double-digit growth in adjusted earnings per share and a 9% increase in revenue
as market participants continued turning to our markets to mitigate their
business risks amid accelerating geopolitical uncertainty.”
“This was a particularly strong quarter, with
interest rate volume increasing 6%, driven by an 18% rise in Treasury futures average daily volume (ADV) and records in our Ultra 10-Year and Ultra T-Bond futures.
We also generated significant growth across agricultural, energy and options
products.”
During the third quarter of 2023, CME recorded an
ADV of 22.3 million contracts. Notably, its non-US ADV showed significant
growth, reaching 6.5 million contracts, which represents an increase of 7% from
the same quarter in 2022.
Comparatively, the company reported an ADV of 24.2 million contracts in August, marking a substantial surge of 14% compared to the
previous year. Notably, this represents the second-highest ADV ever recorded
for the month of August.
Approximately $400 Million in Dividends Distributed
During the period, the company paid dividends of
approximately $400 million. Since implementing the variable dividend policy in
early 2012, CME Group has returned over $22 billion to its shareholders. To
further ensure stability in a market characterized by subdued volatility, CME
Group aims to diversify its revenue sources.
CME Group’s revenue from clearing and transaction
fees for the third quarter totaled $1.1 billion, with a total average rate per
contract amounting to $0.707. Additionally, the revenue from market data was
$168 million. A recent report showed that over 80% of the
company’s revenue is derived from transactions, a figure CME seeks to reduce
by expanding into alternative revenue streams.
CME Group reported a substantial rise in its Q3
profit, attributed to traders seeking a safe haven from market volatility by
using CME Group’s products. The company reported a revenue of $1.3 billion and
operating income of $820 million.
CME Group’s net income surged to $807.8 million, or
$2.25 per share, for the quarter ending on September 30. This marked a significant
improvement of 13.7% from the $710 million, or $1.98 per share, reported during
the same period the previous year.
CME Group‘s Chairman and Chief Executive Officer, Terry Duffy, stated: “CME Group delivered its ninth consecutive quarter of
double-digit growth in adjusted earnings per share and a 9% increase in revenue
as market participants continued turning to our markets to mitigate their
business risks amid accelerating geopolitical uncertainty.”
“This was a particularly strong quarter, with
interest rate volume increasing 6%, driven by an 18% rise in Treasury futures average daily volume (ADV) and records in our Ultra 10-Year and Ultra T-Bond futures.
We also generated significant growth across agricultural, energy and options
products.”
During the third quarter of 2023, CME recorded an
ADV of 22.3 million contracts. Notably, its non-US ADV showed significant
growth, reaching 6.5 million contracts, which represents an increase of 7% from
the same quarter in 2022.
Comparatively, the company reported an ADV of 24.2 million contracts in August, marking a substantial surge of 14% compared to the
previous year. Notably, this represents the second-highest ADV ever recorded
for the month of August.
Approximately $400 Million in Dividends Distributed
During the period, the company paid dividends of
approximately $400 million. Since implementing the variable dividend policy in
early 2012, CME Group has returned over $22 billion to its shareholders. To
further ensure stability in a market characterized by subdued volatility, CME
Group aims to diversify its revenue sources.
CME Group’s revenue from clearing and transaction
fees for the third quarter totaled $1.1 billion, with a total average rate per
contract amounting to $0.707. Additionally, the revenue from market data was
$168 million. A recent report showed that over 80% of the
company’s revenue is derived from transactions, a figure CME seeks to reduce
by expanding into alternative revenue streams.
